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Background: Case payment mechanisms have become the principal means of remunerating hospitals in most
developed countries. Our purpose was to analyse the reimbursement for different types of tissue transfer in five
European countries.
Methods: We looked at common surgical options for pedicled and free flaps. The recipient site of a flap and the
principal diagnosis were systematically modified and processed with national grouper software in order to identify
Diagnosis-Related Groups from which the proceeds were derived. The primary data originated from the database of
the German Institute for the Hospital Remuneration System as aggregate information. We conducted eight
specialist interviews to transfer the available data into clinical practice. Data of real patients were not available and
we rather simulated standard patients to avoid dilution of results.
Results: Altogether, payment for pedicled flaps averaged 5933€ and was 8517€ for free flaps. The comparison of
both flap types within a country revealed significant differences in Germany, Austria and Sweden only (p < 0.001).
Italy has the highest mean proceeds for pedicled flaps, followed by Sweden, Germany, Austria and the UK. This
relationship changes for free flaps with Sweden achieving the highest payments. Overall, reimbursement conformity
is higher for free flaps.
Conclusions: Most countries have procedure-driven payment systems for flap surgery, which additionally can
strongly depend on the diagnosis. Nevertheless the latter does not always justify existing price differences. For the
first time, clinical cases in tissue transfer were compared internationally. In today`s dynamic world of health care, we
should observe other countries` compensation systems to identify ways of improving our own.
Keywords: Tissue transfer, Flaps, Reimbursement, Diagnosis-Related Groups, Health care policy, Health
services researchBackground
Reimbursement systems for hospitals are very complex
and differ between countries. In this context, Diagnosis-
Related Group (DRG) is the most common payment sys-
tem to classify hospital cases into groups with similar
use of resources. Fetter and Thompson created it in
1967 at Yale University [1]. In contrast to fee-for-service
payments, capitation fees and per-diem payment reim-
burses, DRG is a fixed-payment system. The introduc-
tion of lump sum reimbursement by DRG has led to
profound effects on the hospital landscape in the affected* Correspondence: oliver.lotter@freenet.de
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standardization and cost reduction are barred in particular
by fears of quality loss in medical care and revenue de-
clines. Currently, 20 of 34 member countries of the Or-
ganization for Economic Cooperation and Development
(OECD) have adopted DRG-based payment systems [2].
All countries we looked at adopted this system.
Defect reconstruction through flaps often implies cost
intensive and highly elaborate operative therapies using
tremendous resources and requiring special technical pre-
requisites as well as specific microsurgical skills of the op-
erating team. Such therapies are frequently conducted in a
multidisciplinary approach. Since the 1970s, free transfer
of vascularized tissue has become the procedure of choice
in many cases, because this proceed is often able to solvetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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traditional techniques [3]. However, increasing concerns
about the high cost of such therapies continue to be raised
[4]. Furthermore, the difference in pay of the various recon-
structive options carries the risk that treatment decisions are
influenced monetarily. Overall, these developments lead to
an increased utilization of healthcare resources, which must
be mastered by national payment systems.
In the following investigation, the German, Austrian,
Italian, British and Swedish reimbursement systems are
analysed regarding common pedicled and free flaps while
considering various underlying diagnosis as well as differ-
ent recipient regions. Our purpose was to highlight and
discuss special characteristics of reimbursement both na-
tionally and internationally. According to our literature
review, this study is the first to compare different reim-
bursement systems according to specific clinical cases in
reconstructive plastic surgery.Table 1 Allocation of pedicled and free flaps to different
recipient areas
Flap type
Recipient area Pedicled flaps Free flaps
Head and Neck Temporofascial flap Anterolateral thigh flap
Frontal flap Free radial forearm flap
Trunk Latissimus dorsi flap Latissimus dorsi flap
Gracilis flap
Buttocks Gracilis flap Latissimus dorsi flap
Gluteal rotation flap
Biceps femoris flap
Upper extremity Radial forearm flap Anterolateral thigh flap
Groin flap Lateral arm flap
Serratus fascial flap
Lower extremity Gastrocnemius flap Latissimus dorsi flap
Suralis flap Anterolateral thigh flapMethods
The underlying primary data of our analysis originates
from the database of the German Institute for the Hos-
pital Remuneration System of the year 2012 [http://www.
g-drg.de/cms/Archiv/Systemjahr_2012_bzw._Datenjahr_
2010#sm7]. This database contains aggregate and anony-
mized data on patients and billing of all German hospitals
as well as cost data of selected reference hospitals within
the German DRG system (no outpatient services, private
inpatient billing or patients within the Employers` Liability
Insurance). The aggregated data which is codified by
ICD-10- and OPS-Codes (diagnoses and procedures)
can only give some information about the localization of
flaps but does not allow the identification of a specific
flap type. For transfer of the available data into clinical
practice, eight specialists in Plastic Surgery with their
main activity in Reconstructive Plastic Surgery working
at five German, one British and one Italian University
Hospital were interviewed. Furthermore, actual versions
of known international textbooks were used to identify
commonly used flap types with different indications.
Data of real patients were not available nationally or
internationally and we refrained from basing our analysis
on real patient data of a single institution or a few insti-
tutions. However, we expected that some flap operations
were performed more frequently than others in our
European context, irrespective of personal experience
and preferences of decision makers and surgeons in the
single hospitals. In this analysis we rather simulated
standard patients to avoid irrelevant factors such as co-
morbidities and complications to dilute the results and
drift away from the focus.
We looked at 20 flaps altogether, each 10 pedicled and
10 free flaps with recipient sites on head and neck, trunk(except for the breast), buttocks as well as the upper and
lower extremities (Table 1).
In addition to recipient site modification of a flap, the
following matrix for the underlying diagnosis was used
to discover possible differences in the DRG-assignment:
1. open wounds, 2. deep lesions with possible co-damage
of tendons and muscles, 3. third grade open fractures, 4.
infection after operation, 5. osteomyelitis, 6. malignoma,
7. benignoma, 8. full thickness burn injuries. Further-
more, frostbite at hands, feet and nose as well as decu-
bitus ulcers at the head, back, seat area and feet were
analysed separately as they are not applicable to all body
regions. To simulate different clinical situations, the diag-
nosis and – if possible – the operative procedure(s) were
modified. Each combination of diagnosis and procedure(s)
was extended by two additional scenarios (multiple ses-
sions): First, a surgical wound debridement or local exci-
sion of pathological tissue was codified in the same setting
as the flap surgery. Second, the debridement or local exci-
sion was made on day one as a single procedure and re-
peated five days later together with the flap surgery. This
corresponds to a total of 2505 combinations in the 5 dif-
ferent national reimbursement systems (20 flaps × 8 un-
derlying diagnoses × 5 countries × 3 scenarios + frostbite
3 locations × 5 countries × 3 scenarios + decubitus ulcers
4 locations × 5 countries × 3 scenarios).
The diagnoses and procedures were processed to de-
termine the appropriate DRG, using a special grouper
software. We applied the German ID Diacos® grouper
of Firma ID (Berlin), the official Austrian software pack-
age KDok® and the Italian CMS grouper of Fondazione
Medtronic Italia® (Milano) Version 24 [5-8]. In the British
system, Healthcare Resource Groups (HRGs) were derived
from the HRG4 2012/2013 Local Payment Grouper and
Lotter et al. BMC Health Services Research 2014, 14:427 Page 3 of 8
http://www.biomedcentral.com/1472-6963/14/427the reimbursement was then generated by using the na-
tional tariff under Payment by Results (PbR) funding pol-
icy [9]. For Sweden the identification of NordDRGs was
undertaken by the software of DRG System Development
AB® (Stockholm) [10]. All groupers used were in the actual
version of the year 2012.
Each DRG code maps to a relative weight, which leads
to the payment amount for a particular hospital visit.
Furthermore, thresholds of length of stay were deter-
mined. These trimpoints usually serve as adjustment pa-
rameters for medical payments concerning so called
outliers where the hospitalisation time exceeds or falls
below certain limits. For the consistency of data, we as-
sumed a 50 year old male patient without any complica-
tions or relevant comorbidities.
Conversion of Swedish Kronor (SEK) and Great Britain
Pound (GBP) into Euro (€) was performed according
to the mean exchange rates of the year 2011 (1€ = 9.016
SEK = 0.871 GBP) [11].
Purchasing power parities (PPPs) were used to make
payments between the countries comparable. These in-
dicate how many money units are necessary to acquire
the same quantity and quality of goods and services
abroad as inland [12]. One Euro that has been earned in
Germany is worth 6.2% less in Austria, 11.3% less in
Italy, 4.4% less in the UK and 4.5% less in Sweden [13].
We used independent sample t-tests to compare the
thresholds of length of stay and the reimbursement of
the different reconstructive options. The tests indicated
significant differences between the reconstructive options
if the two-sided p-value was lower than the significance
level of p = 0.002. We chose this value to keep the family-
wise error rate for the 25 comparisons that we conducted
at a 0.05 level (0.05/25 = 0.002).
A Medline literature research included the keywords
[(tissue transfer) or (flaps)] and [(Diagnosis-Related Groups)Table 2 Upper threshold of length of stay (uLoS) in pedicled
D AT
Pedicled Free Pedicled Free P
Open wounds 24 41 14 20
Deep lesions 24 41 14 20
Open fractures 28 29 14 20
Infection 25 38 14 20
Osteomyelitis 21 19 14 20
Malignoma 19 19 14 20
Benignoma 21 19 14 20
Burn injuries 21 30 21 20
Mean 23 30 15 20
(SD) (2,75) (9,68) (2,55) (0)
Numbers in brackets indicate one standard error from the mean.
D = Germany, AT = Austria, I = Italy, UK = United Kingdom, S = Sweden.or (reimbursement) or (costs)] and revealed a total of 354
results (status as of 19.06.2012). Out of these, only 18
articles were relevant for our topic.
This manuscript does not report research which requires
approval by ethics committee(s) as no human subjects
were involved.
Results
Altogether, 1,920 combinations of diagnosis and pro-
cedure(s) for pedicled and free flaps were simulated in
the five DRG-systems.
A. DRGs
Nine different DRGs for pedicled tissue transfer and 7
for free flaps were defined in Germany. For Austria, 3
and 1 DRGs were found respectively and in Sweden 7
and 6 DRGs. In Italy, both types of tissue transfer re-
vealed 6 DRGs each and in England only one single
DRG for both pedicled and free flaps was determined.
B. Length of stay
The upper threshold of length of stay (uLoS) is the only
trimpoint available in all countries of our series and is
shown in Table 2. The highest values concerning uLoS for
pedicled flaps are found in Sweden in combination with
burn injuries as the underlying diagnosis (Mean [M] =
47 days, Standard Deviation [SD] = 0 days), followed by
deep lesions, infections and burns (M = 35 days each,
SD = 0 days) in Italy. Regarding free flaps, again Sweden
shows the highest values in burns (M = 47 days, SD =
0 days) followed by open wounds and deep lesions in
Germany (M= 41 days, SD = 0 days). Remarkably, some
flaps for defect coverage of the upper extremity result in a
mean uLoS which is much shorter than for the same flaps
transplanted to other body regions. As expected, the uLoS
in the five countries is generally shorter for pedicled flapsand free flaps (in days)
I UK S
edicled Free Pedicled Free Pedicled Free
12 12 18 18 10 28
35 34 18 18 13 29
23 24 18 18 11 28
35 35 18 18 33 33
24 24 18 18 6 27
24 24 18 18 6 27
24 24 18 18 6 27
35 35 18 18 47 47
27 27 18 18 16 31
(7,96) (7,95) (0) (0) (15,25) (6,89)
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(M = 25 days, SD = 8 days). Using an independent sample
t-test there is a statistically significant difference (p <
0.001) between pedicled and free flaps. When comparing
the uLoS between both flap types within the single coun-
tries, Italy and the UK do not reach the significance level
(p = 0.977 and p = 1.000).
C. Reimbursement
The single values of reimbursement for pedicled and
free flaps are shown in Figures 1 and 2. Italy has the
highest mean proceeds for pedicled flaps (M = 7461€,
SD = 3376€), followed by Sweden (M= 7155€, SD = 7155€),
Germany (M= 5450€, SD = 1898€), Austria (M = 5139€,
SD = 761€) and the UK (M= 4776€, SD = 0€). This rela-
tionship changes for free flaps with Sweden achieving by
far the highest reimbursement (M = 11654€, SD = 3003€).
Proceeds for pedicled flaps with osteomyelitis in Sweden
(M = 11069€, SD = 0€), as well as burn injuries of all
body regions in Italy (M = 14968€, SD = 0€) and Sweden
(M= 17889€, SD = 0€) are in a five-digit range. For free
flaps, this is the case most commonly found in Germany
(range 10912€ - 15875€) except for open fractures, osteo-
myelitis and tumors. Again, Italy shows one of the highest
reimburses for free flaps in burns (M= 14968€, SD = 0€)
and Sweden has all of its flaps reimbursed by five-digit
numbers (range 10045€ - 17889€). Generally, there is only
a slight difference between both types of tissue transfer inFigure 1 Mean reimbursement for pedicled flaps with subdivision int
from the mean. D = Germany, AT = Austria, I = Italy, UK = United KingdomItaly. It is noticeable that both flap types in open fractures,
osteomyelitis as well as benign and malignant tumors lead
to much lower reimbursement in Germany when the re-
cipient site is the upper extremity (all M = 3119€, SD = 0€)
compared to the other body regions. Proceeds in Austria
are very constant except for pedicled flaps in burn injuries
for which more is paid. In Sweden the type of operation
mainly determines the payment and the underlying diag-
nosis only plays a minor role. In general, proceeds are
highest for defect reconstruction after full-thickness burns
in all analysed countries.
The mean value of the five countries is 5933€ (M range
2159€ - 17554€, SD = 2987€) for pedicled flaps compared
to 8517€ (M range 3119€ - 17554€, SD = 3600€) for free
tissue transfer. Significantly higher values were paid for
free flaps than for pedicled flaps (p < 0.001). The com-
parison of both flap types within a country revealed sig-
nificant differences in Germany, Austria and Sweden only
(p < 0.001).
D. Multiple sessions
When looking at the scenarios of multiple sessions, only
Austrian proceeds increased. However this was related
to benign and malignant tumors as well as full-thickness
burns. Regarding scenario I (surgical wound debridement
or local excision in the same setting as the flap surgery)
the average increase amounted to 19% in pedicled and
10% in free flaps. For scenario II (debridement or localo the underlying diagnosis. Error bars indicate one standard error
, S = Sweden.
Figure 2 Mean reimbursement for free flaps with subdivision into the underlying diagnosis. Error bars indicate one standard error from
the mean. D = Germany, AT = Austria, I = Italy, UK = United Kingdom, S = Sweden.
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with the flap surgery), additional proceeds of 36% or 21%
could be found. The additional temporary wound closure
such as Negative Pressure Wound Therapy did not reveal
any changes in the definition of DRGs.
E. Special situations
The reimbursements for frostbite and decubitus ulcers
are shown in Table 3. In Italy and the UK, there isTable 3 Reimbursement for special situations (in Euros)
a) Frostbite
D AT I UK S
Pedicled flaps 5010 5160 5708 4578 6798
Free flaps 10912 9891 5708 4578 12417
Mean 7961 7526 5708 4578 9608
(SD) (4173) (3345) (0) (0) (3973)
b) Decubitus ulcers
D AT I UK S
Pedicled flaps 8702 5160 4117 4578 10601
Free flaps 8702 9891 4117 4578 12614
Mean 8702 7526 4117 4578 11608
(SD) (0) (3345) (0) (0) (1423)
Numbers in brackets indicate one standard error from the mean.
D = Germany, AT = Austria, I = Italy, UK = United Kingdom, S = Sweden.no difference between the two categories of flaps. The
Austrian system shows no variation regarding other un-
derlying diagnoses. A separate DRG for decubitus ulcers is
available in Germany, however it does not distinguish be-
tween pedicled and free flaps. The highest discrimination
can be found in Sweden where different DRGs exist for
pedicled and free flaps as well as for decubitus ulcers and
frostbites.
F. Single-case comparison and purchasing power parities
All single-case reimbursments out of the different coun-
tries were compared with each other regarding the spe-
cific flap used. Altogether 20 different flap types, each
10 pedicled and 10 free flaps, as well as 8 underlying
diagnoses were compared from the five above mentioned
countries. This led to 1600 direct, single-case comparisons
of reimbursement for flaps (Figure 3). Furthermore,
Purchasing power parities (PPPs) were used to improve
the international comparability of the proceeds. When
comparing the native data of pedicled flaps, Italy has most
of the highest reimburses, followed by Austria, Sweden,
Germany and the UK. This relationship changes when in-
tegrating PPPs, placing the UK at the fourth position, thus
overtaking Germany. Concerning reimburses of free flaps,
Sweden is in the first place, followed by Germany, Austria,
then Italy and finally the UK. Austria overtakes Germany







Germany Austria Italy UK Sweden
pedicle ﬂaps - nave data
pedicle ﬂaps - with PPPs
free ﬂaps - nave data
free ﬂaps - with PPPs
Figure 3 Single-case comparison of reimbursement between the countries. The reimburses of the different categories of all countries are
compared among each other. There are a total of 8 underlying diagnoses in each 10 pedicled and 10 free flaps in every country. Thus, 160
scenarios are compared between two countries (8×10×2) with 10 different country pair formations.
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In the present investigation the German, Austrian, Italian,
English and Swedish reimbursement systems were com-
pared regarding surgical treatment through pedicled and
free flaps with different underlying diagnoses in various
body regions. Our aim was to standardize the scenarios to
ensure maximal transparency and comparability. There-
fore, a predefined algorithm to depict the various tissue
transfers both nationally and internationally was applied.
We were surprised to find salient contrasts in thresholds
of length of stay and reimbursement.
Altogether, we found statistically significant lower values
for the upper length of stay (uLoS) for pedicled flaps than
for free flaps. In this context, the authors would like to
underline the importance of the lower threshold (lLoS),
which can only be found in Germany and Austria. Systems
with no lLoS have to be critically judged as encouragers of
“bloody discharges” and bear the risk of quality loss in
medical treatment.
We assumed the reimbursement for free flaps to exceed
that of pedicled flaps. This was the case for the average re-
muneration in Germany (9126€ vs. 5450€), Austria (9891€
vs. 5139€) and Sweden (7036€ vs. 11464€) with statistical
significance. Interestingly this discrepancy was found to
be much lower in Italy (7461€ vs. 7527€). Furthermore inthe UK reimburses for both flap types showed no differ-
ence (both 4578€). For pedicled flaps, the mean value for
reimburses of the five countries was 5933€ and in contrary
8517€ for free tissue transfer. We found no different pro-
cedure codes to distinguish free myocutaneous flaps from
perforator flaps such as for reconstructive breast surgery
in some countries [14]. The authors think this would also
make sense for tissue transfer to other body regions than
the breast, however, no information about potential cost
differences is available so far that could justify such a
distinction.
Overall, in reconstructive surgery the British and
Austrian systems strongly depend on the procedure(s) and
the underlying diagnosis is virtually of no importance. In
contrast, grouping in Italy relies on the diagnosis but – as
in the UK - there is no adequate discrimination between
pedicled and free flaps. The German system is mainly driven
by the underlying diagnosis and less by the procedure(s).
It has to be questioned whether the leading diagnosis is
supposed to have such a strong effect on reimbursement
especially in free flap surgery. One exception might be the
treatment of burns where the multimodality and com-
plexity of treatment is often higher than in other cases.
Our extensive literature research revealed that most
publications concerning flaps were available in the field
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and only a few were related to other body regions [15-31].
All articles we found were published in medical journals
and none in other fields such as health economics or
health services research. Interestingly, all but two papers
were exclusively analysing the costs of tissue transfer, usu-
ally comparing methods of pedicled with free flaps. In this
respect, cost-identification analyses were by far the most
common type [32]. Differences between pedicled and free
tissue transfer were shown to be closely related to length
of operative procedure and its subsequent impact on post-
operative care including longer stays in the intensive care
unit. Mainly in the field of Oromaxillofacial Surgery, other
outcome variables showed no statistically significant dif-
ference [15-19]. In these studies, the reconstruction
type was not significantly associated with overall costs
in the majority of cases. We were surprised about these
findings, as free tissue transfer requires additional tech-
nical equipment (operation microscope), special surgical
skills (microsurgical training), mostly longer operation
times and higher requirements concerning aftercare and
monitoring.
The two papers considering reimbursement were
authored in Anglo-American countries with just one
analysing two different flap types (pedicled vs. free flaps)
and none examining different body regions [22,31]. Fur-
thermore our literature research revealed that all studies
based their analysis only on data of one national institu-
tion, which by far has no claim to universal validity. For
the first time we compared payments internationally avoi-
ding a single-center approach and trying to maximize
standardisation between the countries.
One-stage procedures with debridement or tumor re-
section and tissue transfer during the same hospital stay
were considered separately. The higher resource use in
these cases compared to reconstruction by flaps only
seems logical but reimburses usually remain the same
without considering earlier operative procedures during
the same stay and reimbursing these cases higher. Un-
fortunately, up to now there are no cost-identification
analyses available to point out this problem.
This study is limited through the focus on only the
main diagnosis to create standardised “case vignettes”
avoiding comorbidities and complications to ensure com-
parability and reduce complexity. The selection and distri-
bution of the various flaps was randomly and will strongly
depend on the spectrum of a single department perfor-
ming reconstructive surgery. Furthermore, comparison of
international DRG-related data was impaired by numer-
ous variables such as different structural conditions, or-
ganization and other factors that cannot be taken into
account. The healthcare market is still highly regulated
and free market forces are often underrepresented which
could lead to falsification [33]. As in most cost analyses,where the primary focus has been identification of costs
incurred during the initial hospitalization in which a flap
procedure was performed, we also concentrated on reim-
bursement for the first hospital stay. Consecutive opera-
tions were excluded. Last but not least, Purchasing Power
Parities allowing international comparison depict the sit-
uation of a predefined consumer basket and might not
exactly describe the focus of the health care sector.
It would be interesting to include the cost of each sce-
nario to compare the profit of different tissue transfers
within and among the countries. However, cost data – if
available – often shows less consistency and a large range
throughout a country than reimbursement. The mixture
of completely different treatment cases under the cover of
DRG, resulting in a different consumption of resources is
a major barrier for a transparent cost presentation. There-
fore we recommend in a first step to exclude the diagnosis
from the calculation of reimbursement except for highly
elaborate pathologies such as burns for example. In doing
so, more emphasis could be put on the operation, which
seems to be the main trigger of costs in tissue transfer. In
this context, however, monetary reasons are not allowed
to motivate the surgeon for or against certain specific
therapies.Conclusions
Flap surgery is necessarily individualized and specific pro-
cedures may be indicated in very different conditions and
circumstances, each with a unique pattern of resource use
and often independent of the underlying diagnosis. As
pointed out in our analysis, this is in contrast to many
rigid and inflexible coding systems grouping different flap
procedures under only one single procedure code [30].
This leads us to the question whether there should be a
higher reimbursement discrimination between various re-
constructive options in cases where future in-depth cost
analyses have shown obvious discrepancies. For the first
time, clinical cases in tissue transfer were compared inter-
nationally. The comparison of reimbursement by DRG
should be a useful instrument for benchmarking and re-
finement of a national compensation system while not de-
pending solely on political decisions or country-specific
cost data.
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